The antimicrobial and antibiofilm properties of plant essential oils (EOs) have aroused significant interest for their potential as effective alternatives or supplements in combating microbial infections and biofilm-associated challenges. For these applications, EOs must be encapsulated to overcome some key technical limitations, including high volatility, poor stability, and low solubility. This study aimed to develop microencapsulated EOs derived from two valuable Moroccan medicinal plants, Lavandula stoechas L. and Thymus pallidus Batt., both individually and in combination, using the spray drying method. The antimicrobial and antibiofilm effects of these encapsulated EOs were evaluated against various pathogenic microorganisms using microdilution and crystal violet assays. Key physico-chemical characteristics of the EO microcapsules, including optimal particle size, favorable zeta potential, low water content, and high encapsulation yield and efficiency were observed, indicating strong stability and effective encapsulation. The major chemical compounds identified in the studied EOs were thymol (26.72 %), γ-terpinene (23.26 %), and p-cymene (19.07 %) in T. pallidus EO; and camphor (47.67 %), fenchone (20.78 %), and 1.8-cineole (12.17 %) in L. stoechas EO. The results from antimicrobial assays demonstrated that the encapsulated T. pallidus EO exhibited stronger inhibitory and microbicidal effects against all tested strains, with MIC and MMC values ranging from 0.312 mg/mL to 2.50 mg/mL. The encapsulated EOs combination demonstrated interesting antimicrobial effect, with varying type of interactions depending on the target microorganisms. Additionally, the antibiofilm activity of the microencapsulated EOs combination, evaluated against Staphylococcus aureus, Klebsiella pneumoniae and Bacillus subtilis, showed significant biofilm inhibition with percentages reaching up to 92.68 % at MIC concentration and BIC ranging from 0.05 ± 0.00 mg/mL to 0.17 ± 0.01 mg/mL. The eradication of preformed biofilms was also measured, showing a notable effect with eradication rates exceeding 78 % at concentrations of 4MIC, and BEC values ranging from 0.16 ± 0.02 mg/mL to 1.30 ± 0.37 mg/mL. Overall, these finding indicate that the encapsulated EO combination derived from these two Moroccan medicinal plants presents a promising formulation capable of overcoming the limitations associated with free EOs and contributing to the fight against antimicrobial resistance and biofilm-related challenges.